Updates – Prescription Drugs

2009 2010 2013 2014 2015 2016 2017 2018 2019

protected content Individual Mandate Repealed, Rx Costs in the Crosshairs, ER Mandate Penalties, and More

By now everyone has seen that the final tax reform bill zeroes out the penalties for failing to obtain minimum essential coverage (MEC) in a given month. There are a number of externalities to this, some of which may affect employer plans… More

protected content Nominations News, Rx Costs on the Hill, DRIVE, and America’s Health Rankings

We already sent an update out discussing the nomination hearing of Preston Rutledge, the President’s choice to head up the Employee Benefits Security Administration (EBSA) at the Department of Labor. It was mostly uneventful, with not a lot of discussion of health care… More

protected content Alert: State Law Claims Federally Preempted in Amgen v. Sandoz

Today, the Federal Circuit Court of Appeals released its decision on the state law claims in the dispute between Amgen and Sandoz. This ruling stemmed from the U.S. Supreme Court’s remand of certain state law issues back to the Appeals Court when it handed down its decision on a notice requirement in June… More

protected content ACA Taxes, Big DRIVE Health News, Rx Costs, and More!

Article by James Gelfand, Senior Vice President of Health Policy Hello ERIC members, I hope you’re all doing well. We’re in… More

protected content MHP, Rx Costs, the State of ESI, and More!

I hope you all have had a good week. While Capitol Hill has been focused on tax reform, we have been furiously working on the probably end-of-year package, trying to ensure that employers get some ACA tax relief, and playing defense on a number of issues for which Congress is seeking revenue to pay for other priorities… More

protected content HHS Nominee Hearing Coming, End-of-Year Health Care Legislation, HSA Action, and More

On November 29 at 9:30am, the Senate Health, Education, Labor and Pensions (HELP) Committee will hold a hearing on Alex Azar’s nomination to be Secretary of Health and Human Services (HHS). The Committee hearing is a “courtesy hearing”—it will not be a vote on Azar’s nomination (the Senate Finance Committee is the one that will have to report Azar out to the Senate floor). Azar’s nomination to fill the vacancy left by Secretary Tom Price was announced on November 13 by President Trump… More

protected content Tax reform, Opioids, San Francisco, and More!

Let’s start with this: on the issue of protecting the tax exclusion for employer-sponsored health insurance, we win! For now… More

protected content Market Stabilization, HIPAA Relief, Wellness, Opioids, and More

It has been a busy week in DC, with a lot of movement on health issues. Does this mean anything of substance will necessarily get done? Of course not. But hey, it could happen! I’ve got a number of updates for you below, so let’s get to it… More

protected content BCRA Update, HHS RFI on ACA Regs, Commonwealth on Rx Pricing, and the NYT Discovers Value-Based Ins

By now you have likely seen that the Senate GOP has released a new draft of the Better Care Reconciliation Act (BCRA), their legislation to “repeal and replace” the Affordable Care Act (ACA). We’ll go through the major changes, as well as some other updates… More

protected content Health Reform Update, EO on Rx, EBRI Data, and Mental Health Parity Rules

Good afternoon! We thought this week may be it – crunch time for “repeal and replace,” the final countdown, will it happen or not... turns out not. The vote is now on hold… More

protected content AHCA Rumblings, FDA Bill Advances, HSA Limits, Medicare Hearings, and More!

I’ve got a number of updates for you, no action needed on your part – although please remember to let me know if you have thoughts on plan beneficiary disclosures we can consolidate or eliminate! And keep in mind that next Thursday the 18th is our May Third Thursday Call… More

protected content UFAs Appear, AHCA Update, Individual Market Stability, Rx “Brand Penalties,” and More

There have been a number of developments in the past several days, so I wanted to make sure you all had the latest – no action needed, just info below. I’m looking forward to seeing some of you on Monday in NYC at the In-House Benefits Counsel Network conference, and to seeing many more of you next week at ERIC’s Spring Policy Meeting! Hopefully as many ERIC members as possible will be represented. Now let’s get to the updates… More

protected content Nominations Move, Individual Markets, Litigation Update, and More

Good afternoon. I hope everyone is having a good week. It’s been a pretty busy last 2 weeks, between the executive transition, drama in Congress over nominations, the GOP policy retreat, ERIC’s board meeting last week, and more. Not to mention, a new executive order, specifying that for every new regulation the Administration puts out, they have to eliminate two others! This update will attempt to keep everyone abreast of these ongoing developments… More

2009 2010 2013 2014 2015 2016 2017 2018 2019